Janssens J P, Wittevrongel C, De Loecker W
Anticancer Res. 1984 Jul-Oct;4(4-5):263-7.
Phorbol derivatives (phorbol-12,13-diacetate, phorbol-12,13-dibenzoate, phorbol-12,13-dibutyrate, and phorbol-12-myristate-13-acetate) interact with cortisol on a molecular basis. These molecular interactions are demonstrated via dexamethasone receptor assays and by changes in spectrophotometric characteristics when equimolar solutions of these phorbol compounds together with cortisol are compared to those of the pure solutions. The phorbol compounds characterized by modifications in the molecular ring structure and by substitution at position C20, lose the capacity to bind cortisol. The tumor promoting effects of phorbol compounds are apparently achieved, in addition to other well-known mechanisms, by neutralizing cortisol, thus suppressing its regulatory effect on cell proliferation.
佛波酯衍生物(佛波醇 - 12,13 - 二乙酸酯、佛波醇 - 12,13 - 二苯甲酸酯、佛波醇 - 12,13 - 二丁酸酯和佛波醇 - 12 - 肉豆蔻酸酯 - 13 - 乙酸酯)在分子水平上与皮质醇相互作用。通过地塞米松受体测定以及将这些佛波醇化合物与皮质醇的等摩尔溶液与纯溶液进行比较时分光光度特性的变化来证明这些分子相互作用。以分子环结构修饰和C20位取代为特征的佛波醇化合物失去了结合皮质醇的能力。除了其他众所周知的机制外,佛波醇化合物的促肿瘤作用显然是通过中和皮质醇,从而抑制其对细胞增殖的调节作用来实现的。